Novant Health expands women's healthcare access in the Triad with six new physicians. October 13, 2026 WINSTON-SALEM, N.C. - Novant Health has welcomed six women's health physicians, Drs. Abbey Donahue, Haley Gesse, Joseph Gobern, Jackeline Larker, Gianna Daugherty and Amanda Sherman, to provide comprehensive women's health services in Kernersville and Winston-Salem. The physicians are part of Novant Health's ongoing commitment to expand access to advanced primary and specialty care services across the region. So far in 2026, Novant Health has added more than 80 new physicians and advanced practice providers in the Triad, with 50 more clinicians expected to join by the end of the year. "We are focused on meeting women's healthcare needs through every stage of life," said Davida Henderson, director of the Novant Health Women's & Children's Institute in the Triad region. "From maternity care and gynecological support to hormone therapy and advanced cancer services, our teams are here to provide the expert, compassionate care women deserve." Meet the physicians Donahue joins Novant Health as a board-certified obstetrician-gynecologist with more than seven years of experience. She specializes in maternal-fetal medicine and is passionate about helping patients experiencing high-risk pregnancies and complex maternal health conditions. She earned her medical degree from the University of North Carolina at Chapel Hill School of Medicine and completed her residency at UNC Hospitals in Chapel Hill and her fellowship at Atrium Health Wake Forest Baptist. Donahue sees patients at Novant Health Maternal-Fetal Medicine in Winston-Salem. Gesse joins Novant Health as a board-certified obstetrician-gynecologist. She specializes in providing comprehensive women's health services and is trained in the latest minimally invasive surgical procedures. Gesse earned her medical degree from Marian University College of Osteopathic Medicine in Indianapolis, Indiana. She completed her residency training at Ascension St. Vincent in Indianapolis, Indiana. Gesse sees patients at Novant Health Valaoras & Lewis OB/GYN in Winston-Salem. Gobern joins Novant Health as a board-certified obstetrician-gynecologist with more than 25 years of experience. He specializes in minimally invasive and robotic-assisted surgical solutions for complex benign gynecologic conditions, including severe endometriosis, uterine fibroids and abnormal bleeding. Gobern previously served as health system chair of obstetrics and gynecology care at Main Line Health in Radnor, Pennsylvania, and as a U.S. Army colonel and department chair at Walter Reed National Military Medical Center. He earned his medical degree from the Uniformed Services University's Hebert School of Medicine in Bethesda, Maryland, completed his residency through the San Antonio Uniformed Services Education Consortium and completed his complex benign gynecology fellowship at Walter Reed Army Medical Center. Gobern has received several honors throughout his career, including Philadelphia Magazine's Top Doctor designation from 2021 through 2026. He sees patients at Novant Health Winston-Salem Gynecology. Larker joins Novant Health as an obstetrician-gynecologist with more than six years of experience. She specializes in maternity care, minimally invasive gynecologic surgeries, holistic wellness care and gynecologic oncology screenings. Larker previously worked at WakeMed Cary Hospital, where she provided comprehensive inpatient and outpatient care services. She earned her medical degree from Edward Via College of Osteopathic Medicine in South Carolina and completed her residency at ECU Health Medical Center in Greenville, North Carolina. Larker sees patients at Novant Health Deep River OB/GYN in Kernersville. Daugherty joins Novant Health as a board-certified obstetrician-gynecologist. She specializes in urogynecology and reconstructive pelvic health surgery and regularly treats patients for urinary incontinence, pelvic prolapse and other complex pelvic health conditions. Daugherty, who is also a certified medical Spanish interpreter, earned her medical degree from Rutgers Robert Wood Johnson Medical School. She completed her residency at Baylor College of Medicine and her fellowship at Zucker School of Medicine at Hofstra/Northwell. Daugherty sees patients at Novant Health Pelvic Health Center in Winston-Salem. Sherman joins Novant Health as a urologist specializing in urogynecology and male and female pelvic reconstructive surgery. She treats a wide range of disorders, including urinary incontinence, pelvic organ prolapse, neurogenic bladder dysfunction, urinary tract strictures and painful bladder syndrome. She also performs several minimally invasive urogynecologic procedures. Sherman earned her medical degree from the Jacobs School of Medicine and Biomedical Sciences. She completed her residency at Lahey Hospital and Medical Center and her fellowship at Vanderbilt University Medical Center. She sees patients at Novant Health Pelvic Health Center and Novant Health Urology Baldwin, both in Winston-Salem. * Novant Health Deep River OB/GYN, formerly known as Novant Health WomanCare in Kernersville, is located at 1730 Kernersville Medical Parkway, Suite 104. To schedule an appointment, call 336-481-8750 or visit NovantHealth.org/DeepRiverObGynKernersville. * Novant Health Pelvic Health Center is located at 770 Highland Oaks Drive in Winston-Salem. To schedule an appointment, call 336-718-1970 or visit NovantHealth.org/PelvicHealthWS. * Novant Health Winston-Salem Gynecology is located at 201 Executive Park Blvd. in Winston-Salem. To schedule an appointment, call 336-774-9000 or visit NovantHealth.org/WinstonSalemGynecology. * Novant Health Valaoras & Lewis OB/GYN is located at 245 Charlois Blvd. in Winston-Salem. To schedule an appointment, call 336-659-4777 or visit NovantHealth.org/ValaorasLewisOBGYN. * Novant Health Maternal-Fetal Medicine is located at 1806 S. Hawthorne Road in Winston-Salem. To schedule an appointment, call 336-718-3170 or visit NovantHealth.org/MaternalFetalArdmore. About Novant Health Novant Health is an integrated network of more than 900 locations, including 21 hospitals, nearly 800 physician clinics and urgent care centers, outpatient facilities, and imaging and pharmacy services. This network supports a seamless and personalized healthcare experience for communities in North Carolina and South Carolina. Novant Health is nationally recognized for its unwavering commitment to safety and the highest quality care, and Novant Health serve as a catalyst for healthcare transformation through clinical trials, leading-edge research, innovative care delivery models and robust virtual care networks. The expertise and empathy of its nearly 44,000 team members along with more than 9,100 independent and employed clinicians are at the heart of Its Cause as industry leaders caring for communities across the Carolinas. In 2025, Novant Health provided more than $2.1 billion in community benefit, including financial assistance and services. Media contact. Novant Health media relations

WakeMed, Raleigh Radiology and Siemens Healthineers continue free breast cancer screenings for fifth year. WakeMed, Raleigh Radiology and Siemens Healthineers have launched their fifth annual free mobile mammography event for uninsured women during Breast Cancer Awareness Month. Since starting in 2022, over one thousand women have received screenings aimed at improving early detection rates among underserved communities. Yesterday, 11:13 a.m. Friday, Oct 2 By Old North News WakeMed, Raleigh Radiology and Siemens Healthineers announced on Oct. 2 that they are marking the fifth consecutive year of offering no-cost 3D mammography screenings to uninsured women in the greater Triangle area during Breast Cancer Awareness Month. Since the partnership began in 2022, a total of 1,280 women have received no-cost mammograms through this annual mobile screening event. This October, the Siemens Healthineers mobile mammography bus will be stationed at WakeMed Raleigh Medical Park to provide these services. Screenings are available for uninsured women aged 40 and older beginning Monday, October 5 at WakeMed Raleigh Medical Park at 23 Sunnybrook Road. The schedule includes weekdays from October 5-9 between 11 a.m. and 7 p.m., Saturday, October 10 from 8 a.m. to 4 p.m., and again from October 12-15 between 8 a.m. and 4 p.m. Over the past four years, there were respectively: 258 screenings in 2022; 305 in 2023; 387 in 2024; and another estimated count for subsequent years - totaling more than one thousand opportunities for early detection regardless of ability to pay. The organizations say that by bringing advanced breast imaging directly into the community at no cost each year during Breast Cancer Awareness Month, they aim to help close access gaps caused by financial or other barriers. Both WakeMed and its imaging partner Raleigh Radiology are designated as Breast Imaging Centers of Excellence by the American College of Radiology. All scans taken during this event will be reviewed by Raleigh Radiology with consultation provided as needed with WakeMed physicians on any next steps. Registration is strongly encouraged via their website or phone line for those interested in participating. Insured women are also reminded that annual screening mammograms can be scheduled through WakeMed's Outpatient Imaging locations using MyChart or online scheduling tools. WakeMed contributed to community well-being as a key health care provider in the region, featured healthplexes with emergency departments and outpatient services plus a network of physician practices across various specialties, was recognized as one of the nation's top maternity hospitals, represented the largest health system in Wake County, North Carolina, focused on enhancing community health through exceptional care delivery, and operated under president and CEO Donald Gintzig with oversight from a volunteer Board of Directors - all according to the official website.

Specialty Pharmacy news roundup: September 2026. Investment, consolidation, distribution agreements, accreditations, executive changes, and more, are happening every day in the specialty pharmacy industry. The following are just a few of the many recent activities during the past month. AOM Infusion plans to acquire PromptCare Infusion, Healthcare Dealflow is the first to report. Neither party has issued a press announcement. AOM Infusion is a leading provider of specialty infusion therapy that is backed by private equity firm Revelstoke Capital Partners. PromptCare Infusion is a Waud Capital Partners-backed national provider of respiratory services and home and alternate site infusion therapies. According to a Massachusetts Health Policy Commission filing, AOM's subsidiary, AOM PC Purchaser, LLC, will acquire all equity interests in PromptCare Infusion Buyer, Inc. from PromptCare Intermediate, LP. Flexpoint Ford, a specialist private equity investment firm focused on financial services and adjacent verticals, announced the successful exit of its investment in ArtesRx, LLC to Linden Capital Partners. ArtesRx was established in 2023 by Flexpoint Ford and Dom Meffe, then a Senior Advisor to Flexpoint, to acquire, scale and support pharmacy businesses that serve complex patient populations. Over the course of the partnership, Flexpoint worked closely with management to recruit and build a seasoned executive leadership team, strengthen the Company's sales infrastructure to drive organic growth, and establish an internal M&A engine focused on acquiring complementary businesses. Through this combined organic and acquisition-driven strategy, ArtesRx expanded from three pharmacies predominately serving patients in one state to 16 pharmacies serving patients in 15 states. Bayvrio's approach to pharmacy benefits is reshaping how employers think about the industry. The Bayvrio Pharmacy is the next step in that mission, extending its commitment to best health outcomes directly to patients. The company's grand opening in Tampa was on September 24th. Bayvrio is pairing full-service pharmacy care with critical support, including prior authorization navigation, copay and financial assistance, medication synchronization, and medication therapy management. Biologics was chosen by: * Bristol Myers Squibb as a limited distribution specialty pharmacy provider for ZENBEXUS (iberdomide). This is a newly FDA-approved treatment for certain adults with multiple myeloma who have received prior therapy. * AstraZeneca to be the limited distribution specialty pharmacy provider for ETCAMAH (camizestrant). This drug treats HR+, HER2- advanced breast cancer with a detected ESR1 mutation and is used in combination with a CDK4/6 inhibitor. * Takeda to be part of a limited network of specialty pharmacy providers for MIMRYLO (rusfertide). This therapy treats adults with polycythemia vera (PV). CareMed, owned by PharMerica, has been selected by BioCryst Pharmaceuticals, Inc. as a national pharmacy partner for Orladeyo (berotralstat), an oral treatment used to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 2 years and older. Seven Bridges/CarePartners Pharmacy announced that Scholar Rock's muscle-targeted treatment for SMA, recently approved by the Food and Drug Administration, is now available at Seven Bridges Specialty/CarePartners Pharmacy as part of a limited distribution network. Longitude Rx and WakeMed are announcing a collaboration focused on advancing and supporting the continued development of the health system's specialty pharmacy program. WakeMed is a nationally recognized, 973-bed not-for-profit health care system founded and based in Raleigh, N.C. Through this collaboration, Longitude Rx will bring deep health system specialty pharmacy expertise to support WakeMed in establishing a strong foundation for its program and positioning it for long term growth. Onco360, the nation's leading independent Specialty Pharmacy, has been selected as a pharmacy partner by: * Cycle Pharmaceuticals for Cavhanza (nilotinib) orally disintegrating tablets (ODT), which is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. * Bristol-Myers Squibb for ZENBEXUS (iberdomide), indicated, in combination with daratumumab and hyaluronidase-fihj and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least 1 prior line of therapy including a proteasome inhibitor and an immunomodulatory agent.[1] * AstraZeneca for Etcamah(R)(camizestrant), which is indicated for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor (AI) and CDK4/6 inhibitor therapy, based on a US Food and Drug Administration (FDA)-authorized test. * Takeda as an ultra-narrow limited distribution partner for MIMRYLO(TM)(rusfertide), which is a first-of-its kind rare blood cancer treatment in support of patients managing Polycythemia Vera (PV). Priovant Therapeutics selected Orsini and PANTHERx Rare has been selected to dispense LISRAYA (brepocitinib), a newly approved treatment for adults living with dermatomyositis. Shields Health Solutions announced the evolution of its integrated care model, aimed at delivering connected performance across the specialty care continuum. Among the new capabilities now available through its connected model are 340B IQ(TM), designed to simplify the complexities and manual tasks of maintaining a compliant 340B program, and RxTriage(R), which builds a comprehensive and unified intake workflow, while optimizing site of care for the patient and health system.